To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today." -Dr. Gerald Weissmann

A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal (Federation of the American Societies for Experimental Biology) by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored—without obvious toxic side effects.

"We hope that clinical trial studies in AD patients should yield an extended and a better quality of life as observed in mice upon TFP5 treatment," said Harish C. Pant, Ph.D., a senior researcher involved in the work from the Laboratory of Neurochemistry at the National Institute of Neurological Disorders at Stroke at the National Institutes of Health in Bethesda, MD. "Therefore, we suggest that TFP5 should be an effective therapeutic compound." (Photo by: Cécile Graat)

To make this discovery, Pant and colleagues used mice with a disease considered the equivalent of Alzheimer's. One set of these mice were injected with the small molecule TFP5, while the other was injected with saline as placebo. The mice, after a series of intraperitoneal injections of TFP5, displayed a substantial reduction in the various disease symptoms along with restoration of memory loss. In addition, the mice receiving TFP5 injections experienced no weight loss, neurological stress (anxiety) or signs of toxicity. The disease in the placebo mice, however, progressed normally as expected. TFP5 was derived from the regulator of a key brain enzyme, called Cdk5. The over activation of Cdk5 is implicated in the formation of plaques and tangles, the major hallmark of Alzheimer's disease.

"The next step is to find out if this molecule can have the same effects in people, and if not, to find out which molecule will," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today."

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'I Still Have a Dream' – MLK Jr.'s Niece Rejects SPLC's Hate-Mongering in Powerhouse Testimony

Michigan Town Bans Church From Holding Worship Services: Lawsuit

Cleveland Clinic to Provide $2M for Detransition Care, Won't Perform Sex-Change Procedures for Minors

'Not Above the Law': VP Vance Refers New Fraud Allegations against Tim Walz to DOJ

Confirmed: Gov Tim Walz, AG Keith Ellison Knew for 6 YEARS of Rampant MN Fraud But Said Nothing in Order to 'Keep Somali Votes'

Republican Candidate Steve Hilton Advances in California Governor's Primary Race

Rick Scott: Late LA Mayor Race Results Prove SAVE America is Necessary

Socialist Raman Defeats Spencer Pratt in LA Mayor Race with Last-Minute Vote Surge

The US Will 'Respond' to Iran Downing Army Chopper; Ceasefire in Question

Who Are the 13 Patriots Honored in Freedom Plaza?

The Left Couldn't Pause the Politics for One Lousy Day for 'The Great American State Fair'

One Player Refuses to Wear 'Pride' Hat During LA Dodgers' LGBT Night

What Happened to Spencer Pratt Is Why the Supreme Court Decision on Election DAY Is Key

Kash Patel Touts FBI 'Full-throttle Mission' after Operation Spring Cleaning Yields 615 Indictments/Complaints

Iranian Young People and Students Are Bravely Taking to the Streets Again in Protests against the Islamic Regime

Sirens Blare Throughout Israel as Iran and Houthis Fire Barrage of Missiles

Massive 7.8 Magnitude Earthquake Rocks Southern Philippines, Triggers Tsunami Warnings across Pacific Region [Video]

Why Christianity Is Soaring in Iran While Islam Is Collapsing

Canada's Senate Passes Anti-Christian 'Bible Ban' Bill C-9, Now Heads to House of Commons

Good News: US Private Payrolls Post Biggest Gain Since January 2025

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor